Ryan C. Lynch

Ryan C. Lynch is an Associate Professor at the University of Washington School of Medicine in the Division of Hematology and Oncology and Associate Professor in the Clinical Research Division at Fred Hutch Cancer Center. He specializes in treating Hodgkin lymphoma, aggressive and indolent non-Hodgkin lymphomas, and chronic lymphocytic leukemia (CLL/SLL) at Fred Hutchinson Cancer Center in Seattle.

His educational background includes:

• Bachelor of Arts from Harvard University
• Doctor of Medicine from Boston University School of Medicine
• Residency in Internal Medicine at Washington University, St. Louis
• Fellowship in Hematology/Oncology at Stanford University

Dr. Lynch's research focuses on optimizing novel therapeutic agents through clinical trials for Hodgkin lymphoma and non-Hodgkin lymphomas. His work emphasizes ctDNA-guided treatment de-escalation and combination therapies targeting B-cell malignancies, with particular attention to diffuse large B-cell lymphoma, follicular lymphoma, and CLL/SLL.

He actively leads multiple Phase I/II clinical trials at Fred Hutch, including investigations of polatuzumab vedotin combinations, personalized chemotherapy reduction using ctDNA monitoring, and allogeneic CAR-T consolidation strategies. His clinical practice integrates these research initiatives to advance precision oncology approaches for lymphoma patients.